Cardiomyopathy

Michelle Dimza, Georgia Vasilakis, Justin L Grodin

Read time: 17m 33s

Ignacio Inglessis-Azuaje, João L Cavalcante, Mayra Guerrero, et al

Watch time: 10h 51m 41s (32 videos)

Andrew JS Coats, Stefan Anker

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)

Eric J Hall, Alexander I Papolos, P Elliott Miller, et al

Read time: 23m 25s

Nir Uriel

Watch time: 34m 39s (5 videos)

Sukriti Banthiya, Larissa Check, Jessica Atkins

Read time: 24m 56s

Harold Djodjo Kano, Wei Sun

Read time: 17m 58s

Ossama K Abou Hassan, Ebere Chukwu, John Schmittner, et al

Read time: 11m 14s

Fausto J Pinto, John Spertus, , et al

Alexander G Truesdell, Rhian E Davies, Moemen Eltelbany, et al

Read time: 18 Mins
HFSA 25: Excercise Effects of Aficamten Vs Metoprolol in MAPLE-HCM

Gregory Lewis

Watch time: 5m 7s

Media

AHA 23: Screening for Peripartum Cardiomyopathies Using an AI Enanced Digital Stethoscope

Demilade Adedinsewo

Watch time: 4m 59s
Navigating HCM Management Paradigms with Dr Masri

Ankur Kalra, Ahmad Masri,

Listen time: 39m 42s
Conversations about HCM: Symptoms, Diagnosis and Management

Ankur Kalra,

Watch time: 51m 52s
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Ahmad Masri

Watch time: 6m 54s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

Fausto J Pinto, John Spertus, , et al

HFSA 22: REDWOOD-HCM OLE: KCCQ Scores In Pts With HCM Treated With Aficamten

Sara Saberi

Watch time: 15m 24s

Broadcast

Heart Failure

MI/ACS
Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Andrew JS Coats, Stefan Anker

Media

AHA 25: The AI-SCREEN-CA Study

Nobuyuki Kagiyama

Watch time: 3m 23s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m

Ignacio Inglessis-Azuaje, João L Cavalcante, Mayra Guerrero, et al

Watch time: 10h 51m 41s (32 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Excercise Effects of Aficamten Vs Metoprolol in MAPLE-HCM

Gregory Lewis

Watch time: 5m 7s
HFSA 25: 96-week Analysis from FOREST-HCM

Ahmad Masri

Watch time: 5m 36s
HFSA 25: The ATTRibute-CM Trial

Ahmad Masri

Watch time: 4m 11s
Treatment of Hypertrophic Cardiomyopathy with Dr Tiku Owens

Anjali T Owens

Watch time: 33m 19s
Diagnosing Hypertrophic Cardiomyopathy with Dr Sara Saberi

Sara Saberi

Watch time: 33m 10s

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)

Broadcast

Heart Failure

MI/ACS
Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s
ESC 25: The ODYSSEY-HCM Study

Milind Y Desai

Watch time: 4m 31s

Articles

Novel Therapies in ATTR-CM

Michelle Dimza

,

Georgia Vasilakis

,

Justin L Grodin

,

Published:

29 October 2025

Citation:

US Cardiology Review 2025;19:e21.

DOI:

https://doi.org/10.15420/usc.2025.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 120
  • Downloads: Downloads 8
  • Read time: 17m 33s

Cardiogenic Shock in Restrictive Cardiomyopathies

Ossama K Abou Hassan

,

Ebere Chukwu

,

John Schmittner

,

Yevgeniy Khariton

,

Madison P Bahe

,

Cari Smith

,

Lazaros Nikolaidis

,

Elan Kuriakose

,

Detlef Wencker

,

Jaime A Hernandez-Montfort

,

Published:

29 July 2025

Citation:

US Cardiology Review 2025;19:e15.

DOI:

https://doi.org/10.15420/usc.2024.51
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 425
  • Downloads: Downloads 41
  • Read time: 11m 14s

Transthyretin Cardiac Amyloidosis: A Right-atrial Variant

Narra Lavanya

,

Abraham Oomman

,

Published:

01 April 2025

Citation:

US Cardiology Review 2025;19:e08.

DOI:

https://doi.org/10.15420/usc.2024.30
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 296
  • Downloads: Downloads 29
  • Read time: 6m 18s

Hypertrophic Cardiomyopathy: a Review

Sukriti Banthiya

,

Larissa Check

,

Jessica Atkins

,

Published:

14 October 2024

Citation:

US Cardiology Review 2024;18:e17.

DOI:

https://doi.org/10.15420/usc.2023.21
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1588
  • Downloads: Downloads 129
  • Citations: 4
  • Read time: 24m 56s